معرفی
Dr. Terri Parker is an Assistant Professor of Medicine at Yale School of Medicine, specializing in Hematology and Medical Oncology. She serves as Assistant Medical Director at Smilow Cancer Hospital in North Haven and holds leadership roles in Yale Cancer Center's Protocol Review Committee and ClinicalPath's Multiple Myeloma Committee. Dr. Parker completed her medical training at St. George's University School of Medicine, residency at University of Connecticut Health Center, and hematology/oncology fellowship at Yale.
Her clinical expertise focuses on plasma cell dyscrasias including:
- Multiple myeloma and related disorders
- AL amyloidosis
- Monoclonal gammopathy of undetermined significance (MGUS)
- Plasma cell leukemia
- Waldenstrom's macroglobulinemia
Research interests center on developing novel therapeutic approaches through clinical trials, with particular emphasis on:
- Drug combinations for treatment-resistant disease
- BCMA-targeted immunotherapies
- Real-world outcomes of monoclonal antibody regimens
- Comorbidity management in hematologic disorders
Honors include:
- David S. Fischer Teaching Award (2016)
- Letter of Recognition from University of Connecticut (2006)
Dr. Parker leads a multidisciplinary care team at Smilow Cancer Hospital and mentors medical oncology fellows. She maintains active involvement in several national clinical trials investigating next-generation therapies for plasma cell disorders.
